Stock Trading History of Patou Gary

The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Patou Gary since year 2005. The trader's CIK number is 1283535. At the time of this reporting, Patou Gary is the Director of Oscient Pharmaceuticals Corp (stock ticker symbol OSCI).

Stock purchases, sales, and option exercises reported by *Patou Gary* since 2005.
Trade Date	Symbol	Company Name (Issuer)	Trade Type	Shares	Price ($)	Value ($)
2006-05-31	OSCI	Oscient Pharmaceuticals Corp	Sale	20,000	1.26	25,200
2006-05-22	OSCI	Oscient Pharmaceuticals Corp	Sale	30,000	1.33	39,900
2006-05-22	OSCI	Oscient Pharmaceuticals Corp	Sale	30,000	1.33	39,900
2006-04-25	OSCI	Oscient Pharmaceuticals Corp	Sale	25,000	1.75	43,750
2006-04-26	OSCI	Oscient Pharmaceuticals Corp	Sale	25,000	1.71	42,750
2006-03-30	OSCI	Oscient Pharmaceuticals Corp	Sale	10,000	1.98	19,800
2006-03-20	OSCI	Oscient Pharmaceuticals Corp	Sale	20,000	2.09	41,800
2006-03-21	OSCI	Oscient Pharmaceuticals Corp	Sale	10,000	2.15	21,500
2006-03-03	OSCI	Oscient Pharmaceuticals Corp	Sale	10,000	2.10	21,000
2006-03-03	OSCI	Oscient Pharmaceuticals Corp	Sale	10,000	2.10	21,000
2006-02-27	OSCI	Oscient Pharmaceuticals Corp	Sale	10,000	1.93	19,300
2006-02-10	OSCI	Oscient Pharmaceuticals Corp	Sale	15,000	2.10	31,500
2006-02-07	OSCI	Oscient Pharmaceuticals Corp	Sale	25,000	2.29	57,250
2006-01-27	OSCI	Oscient Pharmaceuticals Corp	Sale	10,000	2.15	21,500
2006-01-12	OSCI	Oscient Pharmaceuticals Corp	Sale	10,000	2.50	25,000
2006-01-09	OSCI	Oscient Pharmaceuticals Corp	Sale	30,919	2.52	78,008
2006-01-03	OSCI	Oscient Pharmaceuticals Corp	Sale	15,000	2.28	34,200
2005-04-26	OSCI	Oscient Pharmaceuticals Corp	Sale	500	2.05	1,025

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Patou Gary (Director of Oscient Pharmaceuticals Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.